Personalized medicine in oncology, the potential role of nuclear medicine imaging
- Author
- Christophe Van De Wiele (UGent) and Gilles Mees (UGent)
- Organization
- Keywords
- CANCER, THERAPY, PET, PROGRESSION, INTEGRATION, AGENTS
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-4265877
- MLA
- Van De Wiele, Christophe, and Gilles Mees. “Personalized Medicine in Oncology, the Potential Role of Nuclear Medicine Imaging.” CURRENT PHARMACEUTICAL DESIGN, vol. 20, no. 14, 2014, pp. 2231–33.
- APA
- Van De Wiele, C., & Mees, G. (2014). Personalized medicine in oncology, the potential role of nuclear medicine imaging.
- Chicago author-date
- Van De Wiele, Christophe, and Gilles Mees. 2014. “Personalized Medicine in Oncology, the Potential Role of Nuclear Medicine Imaging.” CURRENT PHARMACEUTICAL DESIGN.
- Chicago author-date (all authors)
- Van De Wiele, Christophe, and Gilles Mees. 2014. “Personalized Medicine in Oncology, the Potential Role of Nuclear Medicine Imaging.” CURRENT PHARMACEUTICAL DESIGN.
- Vancouver
- 1.Van De Wiele C, Mees G. Personalized medicine in oncology, the potential role of nuclear medicine imaging. Vol. 20, CURRENT PHARMACEUTICAL DESIGN. 2014. p. 2231–3.
- IEEE
- [1]C. Van De Wiele and G. Mees, “Personalized medicine in oncology, the potential role of nuclear medicine imaging,” CURRENT PHARMACEUTICAL DESIGN, vol. 20, no. 14. pp. 2231–2233, 2014.
@misc{4265877, author = {{Van De Wiele, Christophe and Mees, Gilles}}, issn = {{1381-6128}}, keywords = {{CANCER,THERAPY,PET,PROGRESSION,INTEGRATION,AGENTS}}, language = {{eng}}, number = {{14}}, pages = {{2231--2233}}, series = {{CURRENT PHARMACEUTICAL DESIGN}}, title = {{Personalized medicine in oncology, the potential role of nuclear medicine imaging}}, volume = {{20}}, year = {{2014}}, }